NCT05654610 - Real-world Evidence Study on the Performance and Safety of Halova Ovules | Biotech Hunter

Enrollment

249

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions

Vaginal Atrophy

Interventions

DEVICE

Halova

Halova is a class I medical device formulated as vaginal ovules and intended for intravaginal administration in order to promote and/or accelerate the hydration, healing, re-epithelialization and/or soothing of injured, atrophic or irritated vaginal mucosa. The ovules melt evenly in the vaginal mucosa forming a cream with a moisturizing and calming effect that support the restoration of the vaginal epithelium.

Trial Locations (14)

Unknown

Spitalul Clinic Dr. Ion Cantacuzino Bucharest, Bucharest

Med Life Humanitas Cluj-Napoca, Cluj-Napoca

Cabinet Medical - Dr. Saleh K. Majed, Craiova

Cabinet Medical - Dr. Surpanelu Oana, Iași

MediBlue, Iași

Clinica Natisan Pitesti, Piteşti

Cabinet Dr. Rădulescu G. Mihaela Elena, Râmnicu Vâlcea

Ramnicu Valcea, Râmnicu Vâlcea

Cabinet Ginecologic Dr. Popescu Sibiu, Sibiu

Clinica iMED, Sibiu

Pan Medical Sibiu, Sibiu

Bradmed SRL, Târgu Jiu

Clinica Medicala Dr. Cioata Ionel Trifon, Timișoara

Spitalul Judetean de Urgenta Tulcea, Tulcea